PHARMA ENGINEERING ApS: Financial statements 2017
CVR: 35518495
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
PHARMA ENGINEERING ApS (CVR 35518495) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 924,520 and a net result of DKK 40,318 compared with DKK 28,638 the year before. That is a decrease of 32.3% compared with the year before. Equity in the 2017 report amounted to DKK 213,599. The solvency ratio was 30.3%.
- Gross Profit
- DKK 924,520
- Profit/Loss
- DKK 40,318
- Equity
- DKK 213,599
- Total Assets
- DKK 704,802
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 925 t. | 40 t. | 214 t. | - |
| 2016 | - | 1.4 mio. | 29 t. | 225 t. | - |
| 2015 | - | 983 t. | 305 t. | 238 t. | - |
Keep an eye on PHARMA ENGINEERING ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
PHARMA ENGINEERING ApS has published its annual report for 2016. Gross profit came to DKK 1,365,609, and the net result was DKK 28,638.
About PHARMA ENGINEERING ApS
PHARMA ENGINEERING ApS was a Danish company of the type Anpartsselskab based in Roskilde, founded in 2013 and dissolved in 2023. The company was registered under the industry Rådgivende ingeniørvirksomhed inden for produktions- og maskinteknik. The company has 1 employee (2018). In 2021, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -384,684 the year before. Equity in the 2021 report amounted to DKK 0.